I've long resigned myself to sticking ILA in the bottom drawer...

I've long resigned myself to sticking ILA in the bottom drawer and chalking it up to a learning experience - don't buy a biotech so quickly after an IPO - it's a racket. And never listen to a hot copper pumper from another popular biotech with substantial skin in the game (a stock that has also suffered massive drops in share price over the last year). I haven't sold ILA yet and I think I'll continue to hold it, unless I really want some capital losses, but I will say: I think management sucks and they should do something. Yes, I realise they probably don't have anything to announce, which is a shame, but I guess it just makes the claim on the ILA website that they are "solving urgent viral disease threats" and are "focused on the rapid development of antiviral therapeutics" seem like ironic crap.